(FLS) Flowserve - Overview
Sector: Industrials | Industry: Specialty Industrial Machinery | Exchange: NYSE (USA) | Market Cap: 8.784m USD | Total Return: 46.1% in 12m
Avg Turnover: 199M
EPS Trend: 97.7%
Qual. Beats: 0
Rev. Trend: 90.4%
Qual. Beats: -4
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Flowserve Corporation (NYSE: FLS) is a global provider of industrial flow management equipment and services. The company operates through two primary segments: the Flowserve Pumps Division (FPD) and the Flow Control Division (FCD). Its portfolio includes custom-engineered pumps, mechanical seals, automation products, and specialized valves sold under established brands such as Valtek and Durco.
The business model relies heavily on the installed base effect, where the initial sale of complex equipment generates long-term recurring revenue through aftermarket parts, maintenance, and diagnostic services. Flowserve serves high-barrier industries including oil and gas, chemical processing, and power generation, where equipment reliability is critical for safety and operational continuity.
As a key player in the industrial machinery sector, the company is sensitive to global capital expenditure cycles and energy transition trends. Evaluating the companys historical performance metrics on ValueRay can provide deeper insight into its valuation trends. Headquartered in Irving, Texas, Flowserve maintains a distribution network spanning North America, Europe, and the Asia Pacific.
- Global energy transition spending accelerates demand for low-carbon flow control solutions
- Elevated backlog levels in oil and gas sectors drive long-term revenue visibility
- Aftermarket service expansion improves recurring revenue margins and reduces cyclical volatility
- Fluctuating raw material costs and supply chain constraints impact manufacturing operating margins
- Global industrial capital expenditure cycles dictate demand for specialized pump and valve systems
| Net Income: 354.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 3.35 > 1.0 |
| NWC/Revenue: 36.04% < 20% (prev 32.13%; Δ 3.91% < -1%) |
| CFO/TA 0.09 > 3% & CFO 512.7m > Net Income 354.0m |
| Net Debt (1.27b) to EBITDA (683.2m): 1.86 < 3 |
| Current Ratio: 2.22 > 1.5 & < 3 |
| Outstanding Shares: last quarter (128.6m) vs 12m ago -3.05% < -2% |
| Gross Margin: 35.53% > 18% (prev 0.33%; Δ 3.52k% > 0.5%) |
| Asset Turnover: 82.97% > 50% (prev 84.16%; Δ -1.20% > 0%) |
| Interest Coverage Ratio: 7.45 > 6 (EBITDA TTM 683.2m / Interest Expense TTM 78.9m) |
| A: 0.29 (Total Current Assets 3.05b - Total Current Liabilities 1.38b) / Total Assets 5.73b |
| B: 0.75 (Retained Earnings 4.32b / Total Assets 5.73b) |
| C: 0.10 (EBIT TTM 588.1m / Avg Total Assets 5.61b) |
| D: 1.14 (Book Value of Equity 3.94b / Total Liabilities 3.45b) |
| Altman-Z'' = 6.28 = AAA |
| DSRI: 0.96 (Receivables 1.32b/1.36b, Revenue 4.65b/4.61b) |
| GMI: 0.92 (GM 35.53% / 32.52%) |
| AQI: 0.98 (AQ_t 0.34 / AQ_t-1 0.35) |
| SGI: 1.01 (Revenue 4.65b / 4.61b) |
| TATA: -0.03 (NI 354.0m - CFO 512.7m) / TA 5.73b) |
| Beneish M = -3.17 (Cap -4..+1) = AA |
As of May 27, 2026, the stock is trading at USD 73.35 with a total of 2,157,583 shares traded.
Over the past week, the price has changed by +11.25%,
over one month by -16.57%,
over three months by -17.50% and
over the past year by +46.10%.
Flowserve has received a consensus analysts rating of 4.55. Therefore, it is recommended to buy FLS.
- StrongBuy: 8
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 90 | 22.7% |
P/E Trailing = 25.2684
P/E Forward = 16.9205
P/S = 1.8879
P/B = 3.9706
P/EG = 1.6929
Revenue TTM = 4.65b USD
EBIT TTM = 588.1m USD
EBITDA TTM = 683.2m USD
Long Term Debt = 1.66b USD (from longTermDebt, last quarter)
Short Term Debt = 88.4m USD (from shortTermDebt, last quarter)
Debt = 2.07b USD (from shortLongTermDebtTotal, last quarter) + Leases 175.4m
Net Debt = 1.27b USD (calculated: Debt 2.07b - CCE 792.4m)
Enterprise Value = 10.1b USD (8.78b + Debt 2.07b - CCE 792.4m)
Interest Coverage Ratio = 7.45 (Ebit TTM 588.1m / Interest Expense TTM 78.9m)
EV/FCF = 23.03x (Enterprise Value 10.1b / FCF TTM 436.6m)
FCF Yield = 4.34% (FCF TTM 436.6m / Enterprise Value 10.1b)
FCF Margin = 9.38% (FCF TTM 436.6m / Revenue TTM 4.65b)
Net Margin = 7.61% (Net Income TTM 354.0m / Revenue TTM 4.65b)
Gross Margin = 35.53% ((Revenue TTM 4.65b - Cost of Revenue TTM 3.00b) / Revenue TTM)
Gross Margin QoQ = 37.10% (prev 35.94%)
Tobins Q-Ratio = 1.75 (Enterprise Value 10.1b / Total Assets 5.73b)
Interest Expense / Debt = 3.82% (Interest Expense 78.9m / Debt 2.07b)
Taxrate = 19.66% (21.1m / 107.5m)
NOPAT = 472.5m (EBIT 588.1m * (1 - 19.66%))
Current Ratio = 2.22 (Total Current Assets 3.05b / Total Current Liabilities 1.38b)
Debt / Equity = 0.93 (Debt 2.07b / totalStockholderEquity, last quarter 2.21b)
Debt / EBITDA = 1.86 (Net Debt 1.27b / EBITDA 683.2m)
Debt / FCF = 2.92 (Net Debt 1.27b / FCF TTM 436.6m)
Total Stockholder Equity = 2.22b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.31% (Net Income 354.0m / Total Assets 5.73b)
RoE = 15.93% (Net Income TTM 354.0m / Total Stockholder Equity 2.22b)
RoCE = 15.14% (EBIT 588.1m / Capital Employed (Equity 2.22b + L.T.Debt 1.66b))
RoIC = 10.63% (NOPAT 472.5m / Invested Capital 4.44b)
WACC = 10.22% (E(8.78b)/V(10.8b) * Re(11.90%) + D(2.07b)/V(10.8b) * Rd(3.82%) * (1-Tc(0.20)))
Discount Rate = 11.90% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -46.67 | Cagr: -1.19%
[DCF] Terminal Value 72.17% ; FCFF base≈355.6m ; Y1≈407.6m ; Y5≈599.9m
[DCF] Fair Price = 43.13 (EV 6.79b - Net Debt 1.27b = Equity 5.51b / Shares 127.8m; r=10.22% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 97.71 | EPS CAGR: 29.35% | SUE: 0.46 | # QB: 0
Revenue Correlation: 90.42 | Revenue CAGR: 5.32% | SUE: -2.72 | # QB: -4
EPS current Quarter (2026-06-30): EPS=0.86 | Chg30d=-11.61% | Revisions=-73% | Analysts=11
EPS next Quarter (2026-09-30): EPS=1.06 | Chg30d=-0.98% | Revisions=-14% | Analysts=11
EPS current Year (2026-12-31): EPS=4.06 | Chg30d=-2.08% | Revisions=-71% | GrowthEPS=+11.6% | GrowthRev=+3.2%
EPS next Year (2027-12-31): EPS=4.61 | Chg30d=-1.69% | Revisions=-54% | GrowthEPS=+13.6% | GrowthRev=+7.2%
[Analyst] Revisions Ratio: -73%